loader
Please Wait
Applying Filters...

Looking for Prestwick3_000861? Find Granulation used in Prestwick3_000861 to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 32Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3SPI Pharma

02 2Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

03 38BASF

04 2DFE Pharma

05 1Ingredion Pharma Solutions

06 8Kerry

07 1Kima Chemical

08 6Microlex e.U

09 2Novo Excipients

10 2Pharmatrans-Sanaq

11 1Pluviaendo

12 1Prachin Chemical

13 4Sigachi Industries

14 2The Dow Chemical Company

15 2Ulanqab Kema New Material

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

Brand Name : Aluminum Hydroxide 0200

Excipient Details : Aluminum hydroxide dried gel product (powder) 0200 is typically used in wet granulation processes to manufacture antacid tablets.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.16-0.25; PSD D50: 12 µm

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Dosage Form : Tablet

Category : Granulation

Brand : ALUMINUM HYDROXIDE 0200

Applications : Aluminum hydroxide dried gel product (powder) 0200 is typically used in wet granulation processes to manufacture antacid tablets.

Pharmacopoeia Ref : USP, EP

Technical Specs : Tapped Density: 0.16-0.25; PSD D50: 12 µm

Grade : Oral

arrow

04

arrow
OTS 2025
Not Confirmed
arrow
OTS 2025
Not Confirmed

Brand : KOLLIDON SR

Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specs : Not Available

Grade : Not Available

arrow
blank

06

arrow
OTS 2025
Not Confirmed